Skip to search boxSkip to navigationSkip to main content

MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation

  • Eugene Chang(corresponding author)
    ,
  • Kyung Sun Heo
    ,
  • Chang Hoon Woo
    ,
  • Hakjoo Lee
    ,
  • Nhat Tu Le
    ,
  • Tamlyn N. Thomas
*Corresponding author for this work
  • University of Rochester
    ,
  • Yeungnam University
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Actin filament remodeling regulates several endothelial cell (EC) processes such as contraction, migration, adhesion, and shape determination. Mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2)-mediated phosphorylation of heat-shock protein 27 kDa (HSP27) promotes actin filament remodeling, but little is known about the regulation of this event in ECs.We found that tumor necrosis factor-α (TNF-α) SUMOylated MK2 at lysine (K)-339 affected EC actin filament organization and migration. Loss of the MK2 SUMOylation site (MK2-K339R) increased MK2 kinase activity and prolonged HSP27 phosphorylation, enhancing its effects on actin filament-dependent events. Both TNF-α-mediated EC elongation and steady laminar shear stress-mediated EC alignment were increased by MK2-K339R. Moreover, kinase-dead dominant-negative MK2 (DN-MK2) inhibited these effects. Cell migration is a dynamic process regulated by actin filament remodeling. Both wild-type MK2 (WT-MK2) and DN-MK2 significantly enhanced TNF-mediated inhibition of EC migration, and MK2-K339R further augmented this effect. Interestingly, the p160-Rho-associated coiled-coil kinase (ROCK) inhibitor Y-27632 reversed this effect by MK2-K339R, which strongly suggests that both excessive and insufficient levels of actin filament remodeling canblockECmigration.Ourstudyshows that MK2 SUMOylation is a new mechanism for regulating actin filament dynamics in ECs.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 2527-2537 (11 pages)

Journal (Volume, Issue Number)

Blood (Volume 117, Issue 8)

Publication milestones

  • Published - 02/24/2011

Publication status

Published - 02/24/2011

ISSN

0006-4971

Publication IDs

  • Scopus: 79952181259
  • PubMed: 21131586

Publication metrics

Metrics

SciVal
FWCI
0.97
SciVal
Author count
8
SciVal
citations
33
SciVal
Paper percentile
86
Scopus
citations
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
43
Citation count
42

Funding Details

FunderFunding number
NHLBI
R01HL064839